Rahul Guha, the CEO of rel=”dofollow” href=”https://economictimes.indiatimes.com/thyrocare-technologies-ltd/stocks/companyid-60244.cms” target=”_blank”>Thyrocare, will succeed Shah as the Pharmeasy CEO. API Holdings had acquired a 66.1% stake in Thyrocare for Rs 4,546 crore in June 2021. Thyrocare is listed in the public markets, while Pharmeasy is yet to float an initial public offering.
The board of directors of API Holdings Limited… has approved the additional responsibility…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.fyi/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)